WAM
GHDX

Wealthspire Advisors (Maryland)’s Genomic Health, Inc. GHDX Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-461
Closed -$32K – 2441
2019
Q1 		$32K Buy
+461
New +$34.2K ﹤0.01% 1087

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s GHDX Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 461 shares — an estimated $32K sold.

Wealthspire Advisors (Maryland) first reported a position in GHDX in Q1 2019 and held it in 1 quarter. The position peaked at $32K in Q1 2019. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 461 Genomic Health, Inc. shares in Q2 2019, an estimated $32K.
  • Wealthspire Advisors (Maryland) first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 1 quarter.
  • Wealthspire Advisors (Maryland)'s Genomic Health, Inc. position peaked at $32K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.